AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2023
Jun 2, 2023
32559_dirs_2023-06-02_4ffaf82a-dba1-4324-a664-06ca297fe01d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2023-05-31
Reporting Person: Yoon Seokho Bryan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-31 | Common Stock | P | 9997.00 | $1.41 | Acquired | 17656.00 | Direct |
Footnotes
F1: Includes the purchase of 9,997 shares under the Terns Employee Stock Purchase Plan on May 31, 2023.